TrendPulse Logo

Author Correction: Phenome-wide analysis of copy number variants in 470,727 UK Biobank genomes | Nature

Source: NatureView Original
scienceMarch 31, 2026

Download PDF

Subjects

- Genome-wide association studies

- Personalized medicine

- Structural variation

- Target identification

The Original Article was published on 04 February 2026

Correction to: Nature https://doi.org/10.1038/s41586-025-10087-x Published online 4 February 2026

In the version of the article initially published, Dimitrios Vitsios (Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK) was missing from the list of AstraZeneca Genomics Initiative members and has now been added to the HTML and PDF versions of the article.

Author information

Author notes- These authors contributed equally: Quanli Wang, Slavé Petrovski, Keren Carss

Authors and Affiliations

- Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK

Xueqing Zoe Zou, Fengyuan Hu, Oliver S. Burren, Karyn Megy, Eleanor Wheeler, Santosh S. Atanur, Marcin Karpinski, Douglas Loesch, Zammy Fairhurst-Hunter, Sri V. V. Deevi, Erin Oerton, Sean Wen, Xiao Jiang, Cecilia Salvoro, Jonathan Mitchell, Abhishek Nag, Ben Hollis, Amanda O’Neill, Lauren Anderson-Dring, Sophia Cameron-Christie, Bram Prins, Manik Garg, Carolina Haefliger, Kousik Kundu, Margarida Lopes, Kieren Lythgow, Meeta Maisuria-Armer, Dorota Matelska, Arwa Raies, Helen Stevens, Ioanna Tachmazidou, Coralie Viollet, Dimitrios Vitsios, Anna Cuomo, Daniel Elias Martin Herranz, Gabrielle Baumberg, Natalia Frydrych, Luca Stefanucci, Anna Maria Tsakiroglou, Rahul Sharma, Jen Harrow, Stewart MacArthur, Sebastian Wasilewski, Sean O’Dell, Katherine R. Smith, Margarete Fabre, Slavé Petrovski & Keren Carss

- Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Shanghai, China

Haiyi Lou, Lily Wang & Lifeng Tian

- Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA

Xiaoyin Li, Benjamin Pullman & Sonja Hess

- Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA

Qiang Wu, Ryan S. Dhindsa & Quanli Wang

- Department of Mathematics, University of Tennessee, Knoxville, TN, USA

Qiang Wu

- Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Boston, MA, USA

Jorge L. Del-Aguila & Guillermo del Angel

- Department of Haematology, University of Cambridge, Cambridge, UK

Margarete Fabre

- Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK

Margarete Fabre

- Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA

Ryan S. Dhindsa

- Jan and Dan Duncan Neurological Research Institute, Texas Children’s Hospital, Houston, TX, USA

Ryan S. Dhindsa

- Department of Medicine, University of Melbourne, Austin Health, Melbourne, Victoria, Australia

Slavé Petrovski

- Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

Mohammad Bohlooly-Y

- Bioscience Renal, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

Lisa Buvall, Mark Lal, Rob Menzies & Anish Konkar

- Bioscience Asthma and Skin Immunity, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK

Suzanne Cohen, Yoichiro Ohne & Xavier Romero Ros

- Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

Regina F. Danielson

- Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK

Andrew Davis

- Alexion, AstraZeneca Rare Disease, Boston, MA, USA

Wei Ding, Yupu Liang & Bill Mowrey

- Early Oncology, Oncology R&D, AstraZeneca, Waltham, MA, USA

Brian Dougherty

- Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

Benjamin Georgi & Daniel Muthas

- Clinical Development, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK

Andrew Harper

- Translational Science and Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

Mårten Hammar, Anna Reznichenko & Anna Walentinsson

- Bioscience Immunology, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK

Richard N. Hanna

- Translational Science and Experimental Medicine, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK

Ian Henry, Glenda Lassi & Benjamin Challis

- Oncology Data Science, Oncology R&D, AstraZeneca, Waltham, MA, USA

Zhongwu Lai

- Precision Medicine and Biosamples, Oncology R&D, AstraZeneca, Cambridge, UK

Ruth March

- Early Clinical Development, Research and Early Development, Cardiovasc

Author Correction: Phenome-wide analysis of copy number variants in 470,727 UK Biobank genomes | Nature | TrendPulse